Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $4.94 Analyst target: $16.67 Upside: 237.45%
LeonaBio, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company is headquartered in Bothell, Washington.
See the full interactive analysis & chart →Informational only — not investment advice.